---
figid: PMC8964367__fphar-12-762654-g003
figtitle: 'Berberine: A Review of its Pharmacokinetics Properties and Therapeutic
  Potentials in Diverse Vascular Diseases'
organisms:
- Salvia miltiorrhiza
- Melia azedarach
- Coptis chinensis
- Berberis vulgaris
- Phellodendron amurense
- Penthorum chinense
- Berberis sibirica
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Oryctolagus cuniculus
- Danio rerio
- Opsanus beta
- Homo sapiens
pmcid: PMC8964367
filename: fphar-12-762654-g003.jpg
figlink: /pmc/articles/PMC8964367/figure/F3/
number: F3
caption: 'Schematic representation of the possible mechanism of anti-vasculature in
  heart activity of berberine. Elevated miR-29b can activate the Akt signaling pathway,
  thus promoting angiogenesis and cell proliferation and migration to improve vasculature
  in heart. Increased inflammation, oxidative stress, and ER stress can induce apoptosis
  of vascular endothelial cells. These adverse effects on vasculature in heart can
  be reversed by berberine. Abbreviations: Akt, protein kinase B; Bax, Bcl-2 associated
  X protein; Bcl-2, B-cell lymphoma 2; eNOS, endothelial nitric oxide synthase; ER,
  endoplasmic reticulum; FGF-2, fibroblast growth factor 2; ICAM-1, intercellular
  adhesion molecule 1; IL-1β, interleukin 1β; MAPK, mitogen-activated protein kinase;
  MCP-1, monocyte chemoattractant protein 1; NF-κB, nuclear factor κB; PI3K, phosphoinositide
  3-kinase; ROS, reactive oxygen species; SIRT-1, silent information regulator 1;
  TNF-α, tumor necrosis factor α; TSP-1, thrombospondin 1; VEGF, vascular endothelial
  growth factor; VSMCs, vascular smooth muscle cells.'
papertitle: 'Berberine: A Review of its Pharmacokinetics Properties and Therapeutic
  Potentials in Diverse Vascular Diseases.'
reftext: Xiaopeng Ai, et al. Front Pharmacol. 2021;12:762654.
year: '2021'
doi: 10.3389/fphar.2021.762654
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: berberine | cardiovascular disease | cerebrovascular disease | diabetes
  mellitus | pharmacokinetics
automl_pathway: 0.9380747
figid_alias: PMC8964367__F3
figtype: Figure
organisms_ner:
- Oryctolagus cuniculus
- Bos taurus
redirect_from: /figures/PMC8964367__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8964367__fphar-12-762654-g003.html
  '@type': Dataset
  description: 'Schematic representation of the possible mechanism of anti-vasculature
    in heart activity of berberine. Elevated miR-29b can activate the Akt signaling
    pathway, thus promoting angiogenesis and cell proliferation and migration to improve
    vasculature in heart. Increased inflammation, oxidative stress, and ER stress
    can induce apoptosis of vascular endothelial cells. These adverse effects on vasculature
    in heart can be reversed by berberine. Abbreviations: Akt, protein kinase B; Bax,
    Bcl-2 associated X protein; Bcl-2, B-cell lymphoma 2; eNOS, endothelial nitric
    oxide synthase; ER, endoplasmic reticulum; FGF-2, fibroblast growth factor 2;
    ICAM-1, intercellular adhesion molecule 1; IL-1β, interleukin 1β; MAPK, mitogen-activated
    protein kinase; MCP-1, monocyte chemoattractant protein 1; NF-κB, nuclear factor
    κB; PI3K, phosphoinositide 3-kinase; ROS, reactive oxygen species; SIRT-1, silent
    information regulator 1; TNF-α, tumor necrosis factor α; TSP-1, thrombospondin
    1; VEGF, vascular endothelial growth factor; VSMCs, vascular smooth muscle cells.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCL-2
  - BAX
  - TNF
  - NOS3
  - SIRT1
  - FGF2
  - VEGFA
  - MCP-1
  - BCL2
  - PIK3CB
  - AKT1
  - MAPK14
  - CCL2
---
